干扰素调节因子4的相关研究进展

ISSN:2705-098X(P)

EISSN:2705-0505(O)

语言:中文

作者
李媛媛,袁 霞
文章摘要
干扰素调节因子4(IRF4)是IRF家族中具有独特生物学特性的转录因子,在免疫细胞分化、肿瘤发生及自身免疫病中发挥重要作用。近年来,随着单细胞多组学技术、基因编辑和结构生物学的突破,IRF4的功能及其在疾病中的调控机制得到深入解析。本文系统综述IRF4的结构特征、表观调控模式,及其在血液系统恶性肿瘤、自身免疫病中的最新研究进展。
文章关键词
IRF4;分子特性;调控机制;相关疾病研究
参考文献
[1] NGUYEN H,HISCOTT J,PITHA P M.The growing family of interferon regulatory factors[J].Cytokine Growth Factor Rev, 1997,8(4):293-312. [2] WANG L,ZHU Y,ZHANG N,et al.The multiple roles of interferon regulatory factor family in health and disease[J].Signal Transduct Target Ther,2024,9(1):282. [3] 王雪,路丽明.IRF4:调控多种免疫细胞谱系分化及命运决定的关键分子[J].现代免疫学,2024,44(02):89-95. [4] LI C,LU W,ZHANG H.BTB domain and CNC homolog 2:A master regulator that controls immune response and cancer progression[J]. Biochim Biophys Acta Rev Cancer,2025,1880(3):189325. [5] SHAO W,WANG Y,FANG Q,et al.Epigenetic recording of stimulation history reveals BLIMP1-BACH2 balance in determining memory B cell fate upon recall challenge[J].Nat Immunol,2024,25(8):1432-44. [6] KLEIN U,CASOLA S,CATTORETTI G,et al.Transcription factor IRF4 controls plasma cell differentiation and class-switch recombination[J].Nat Immunol,2006,7(7):773-82. [7] PATTERSON D G,KANIA A K,PRICE M J,et al.An IRF4-MYC-mTORC1 Integrated Pathway Controls Cell Growth and the Proliferative Capacity of Activated B Cells during B Cell Differentiation In Vivo[J].J Immunol,2021,207(7):1798-811. [8] SUN X,GUAN G,DAI Y,et al.microRNA-155-5p initiates childhood acute lymphoblastic leukemia by regulating the IRF4/CDK6/CBL axis[J].Lab Invest,2022,102(4):411-21. [9] ZHOU S,YE S,CHEN L,et al.Interferon Regulatory Factor 4 Recruits Immature B Cells to Signal Tertiary Lymphoid Structure Immaturity and Progression of Clear Cell Renal Cell Carcinoma[J].Int J Biol Sci,2025,21(9):3827-51. [10] SANTOSA E K,KIM H,RüCKERT T,et al.Control of nutrient uptake by IRF4 orchestrates innate immune memory[J].Nat Immunol, 2023,24(10):1685-97. [11] ZHANG X,YIN Z,WU J,et al.IRF4 expression by NK precursors predetermines exhaustion of NK cells during tumor metastasis[J].Nat Immunol,2025,26(7):1062-73. [12] CANARIA D A,RODRIGUEZ J A,WANG L,et al.Tox induces T cell IL-10 production in a BATF-dependent manner[J].Front Immunol,2023,14:1275423. [13] ZECCHINI V,PAUPE V,HERRANZ-MONTOYA I,et al.Fumarate induces vesicular release of mtDNA to drive innate immunity[J]. Nature,2023,615(7952):499-506. [14] YANG Y,WANG Y,WANG Z,et al.ECSIT facilitates memory CD8(+)T cell development by mediating fumarate synthesis during viral infection and tumorigenesis[J].Nat Cell Biol,2024,26(3):450-63. [15] HO I C,TAI T S,PAI S Y.GATA3 and the T-cell lineage:essential functions before and after T-helper-2-cell differentiation[J].Nat Rev Immunol,2009,9(2):125-35. [16] WALKER J A,MCKENZIE A N J.T(H)2 cell development and function[J].Nat Rev Immunol,2018,18(2):121-33. [17] LEE W H,JANG S W,KIM H S,et al.BATF3 is sufficient for the induction of Il9 expression and can compensate for BATF during Th9 cell differentiation[J].Exp Mol Med,2019,51(11):1-12. [18] LIU X,NURIEVA R I,DONG C.Transcriptional regulation of follicular T-helper(Tfh)cells[J].Immunol Rev,2013,252(1):139-45. [19] ZHANG J Z,ZHANG L,DING X,et al.Design,synthesis and biological evaluation of bisnoralcohol derivatives as novel IRF4 inhibitors for the treatment of multiple myeloma[J].Eur J Med Chem,2025,285:117240. [20] MONDALA P K,VORA A A,ZHOU T,et al.Selective antisense oligonucleotide inhibition of human IRF4 prevents malignant myeloma regeneration via cell cycle disruption[J].Cell Stem Cell,2021,28(4):623-36.e9. [21] BARROCA H,MARQUES C,SOARES M J.Large B-cell lymphoma with IRF4 rearrangement-Fine needle biopsy-Report of a case with an atypical presentation[J].Diagn Cytopathol,2023,51(11):E322-e7. [22] CUTSHALL H,PATEL V M,FERGUSON P E,et al.Large B-cell Lymphoma With Interferon Regulatory Factor 4 Rearrangement Presenting as a Primary Central Nervous System Lymphoma in the Brain[J].Cureus,2025,17(5):e83753. [23] GAO J,LI C,LIN X,et al.Role of IRF4 in mediating plasmablast differentiation in diffuse large B-cell lymphomas via mTORC1 pathway[J].Ann Hematol,2025,104(4):2449-59. [24] WU D,WU Y,LIU J L,et al.Association between HLA-Cw*0602 polymorphism and psoriasis risk:a meta-analysis[J].Genet Mol Res, 2011,10(4):3109-20. [25] YU Y,WANG Y,CHEN W,et al.Antisense oligonucleotides targeting IRF4 alleviate psoriasis[J].Acta Pharm Sin B,2025,15(7):3575-90. [26] HE S,DING H,CHEN L,et al.Repression of interferon regulatory factor-4(IRF4)hyperactivation restricts murine lupus[J].Signal Transduct Target Ther,2023,8(1):188. [27] ZHANG R,HUANG W,ZHAO T,et al.Comprehensive analysis and validation of autophagy-related gene in rheumatoid arthritis[J]. Front Cell Dev Biol,2025,13:1563911.
Full Text:
DOI